Vai al contenuto principale della pagina

Polyamine Metabolism in Disease and Polyamine-Targeted Therapies



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Murray-Stewart Tracy Visualizza persona
Titolo: Polyamine Metabolism in Disease and Polyamine-Targeted Therapies Visualizza cluster
Pubblicazione: MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica: 1 electronic resource (240 p.)
Soggetto non controllato: protein synthesis in cancer
neuroblastoma
epigenetics
Drosophila imaginal discs
pneumococcal pneumonia
transgenic mice
spermidine/spermine N1-acetyl transferase
?-difluoromethylornithine
MYC
skeletal muscle
protein expression
curcumin
colorectal cancer
autophagy
human embryonic kidney 293 (HEK293)
melanoma
tumor immunity
Snyder-Robinson Syndrome
Streptococcus pneumoniae
B-lymphocytes
autoimmunity
spermine oxidase
cell differentiation
diferuloylmethane
immunity
antizyme
transgenic mouse
polyamine
hirsutism
chemoprevention
CRISPR
transglutaminase
polyamine analogs
NF-?B
spermine synthase
atrophy
aging
oxidative stress
mast cells
African sleeping sickness
pancreatic ductal adenocarcinoma
eflornithine
carcinogenesis
ornithine decarboxylase
polyamine transport inhibitor
putrescine
neutrophils
spermidine
untranslated region
spermine
polyphenol
M2 macrophages
polyamine transport system
metabolism
difluoromethylorthinine
DFMO
antizyme inhibitors
capsule
polyamine transport
eosinophils
MCF-7 cells
difluoromethylornithine
polyamine metabolism
mutant BRAF
polyamines
cadaverine
proteomics
airway smooth muscle cells
breast cancer
X-linked intellectual disability
complementation
T-lymphocytes
bis(ethyl)polyamine analogs
antizyme 1
cancer
osteosarcoma
Sommario/riassunto: Polyamines are ubiquitous polycations essential for all cellular life. The most common polyamines in eukaryotes, spermine, spermidine, and putrescine, exist in millimolar intracellular concentrations that are tightly regulated through biosynthesis, catabolism, and transport. Polyamines interact with, and regulate, negatively charged macromolecules, including nucleic acids, proteins, and ion channels. Accordingly, alterations in polyamine metabolism affect cellular proliferation and survival through changes in gene expression and transcription, translation, autophagy, oxidative stress, and apoptosis. Dysregulation of these multifaceted polyamine functions contribute to multiple disease processes, thus their metabolism and function have been targeted for preventive or therapeutic intervention. The correlation between elevated polyamine levels and cancer is well established, and ornithine decarboxylase, the rate-limiting biosynthetic enzyme in the production of putrescine, is a bona fide transcriptional target of the Myc oncogene. Furthermore, induced polyamine catabolism contributes to carcinogenesis that is associated with certain forms of chronic infection and/or inflammation through the production of reactive oxygen species. These and other characteristics specific to cancer cells have led to the development of polyamine-based agents and inhibitors aimed at exploiting the polyamine metabolic pathway for chemotherapeutic and chemopreventive benefit. In addition to cancer, polyamines are involved in the pathologies of neurodegenerative diseases including Alzheimer’s and Parkinson’s, parasitic and infectious diseases, wound healing, ischemia/reperfusion injuries, and certain age-related conditions, as polyamines are known to decrease with age. As in cancer, polyamine-based therapies for these conditions are an area of active investigation. With recent advances in immunotherapy, interest has increased regarding polyamine-associated modulation of immune responses, as well as potential immunoregulation of polyamine metabolism, the results of which could have relevance to multiple disease processes. The goal of this Special Issue of Medical Sciences is to present the most recent advances in polyamine research as it relates to health, disease, and/or therapy.
Titolo autorizzato: Polyamine Metabolism in Disease and Polyamine-Targeted Therapies  Visualizza cluster
ISBN: 3-03921-153-6
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910367757003321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui